Royce & Associates LP held its position in shares of Maximus, Inc. (NYSE:MMS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 52,995 shares of the health services provider’s stock at the end of the 2nd quarter. Royce & Associates LP owned about 0.08% of Maximus worth $3,319,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Neuburgh Advisers LLC increased its position in Maximus by 1.9% in the 1st quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock valued at $105,000 after acquiring an additional 32 shares during the period. Acrospire Investment Management LLC increased its position in Maximus by 183.3% in the 1st quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $106,000 after acquiring an additional 1,100 shares during the period. Glen Harbor Capital Management LLC increased its position in Maximus by 1.9% in the 1st quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock valued at $145,000 after acquiring an additional 44 shares during the period. First Bank & Trust increased its position in Maximus by 4.2% in the 2nd quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock valued at $157,000 after acquiring an additional 101 shares during the period. Finally, Elkfork Partners LLC increased its position in Maximus by 1.9% in the 1st quarter. Elkfork Partners LLC now owns 2,968 shares of the health services provider’s stock valued at $185,000 after acquiring an additional 56 shares during the period. Hedge funds and other institutional investors own 97.23% of the company’s stock.
Maximus, Inc. (NYSE MMS) opened at 60.62 on Monday. The company has a market capitalization of $3.93 billion, a price-to-earnings ratio of 19.43 and a beta of 1.37. The firm’s 50-day moving average price is $60.39 and its 200-day moving average price is $61.35. Maximus, Inc. has a 52 week low of $43.69 and a 52 week high of $64.97.
Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. During the same quarter in the previous year, the company posted $0.79 EPS. Maximus’s revenue was down 2.7% on a year-over-year basis. On average, equities analysts expect that Maximus, Inc. will post $3.13 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 31st. Investors of record on Tuesday, August 15th were given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend was Friday, August 11th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
In other Maximus news, CEO Richard A. Montoni sold 29,203 shares of Maximus stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the sale, the chief executive officer now owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction on Friday, June 16th. The stock was sold at an average price of $63.56, for a total transaction of $508,480.00. Following the sale, the president now directly owns 35,904 shares of the company’s stock, valued at approximately $2,282,058.24. The disclosure for this sale can be found here. Insiders sold a total of 108,403 shares of company stock valued at $6,586,731 in the last 90 days. 3.10% of the stock is currently owned by corporate insiders.
Several analysts recently commented on the company. Robert W. Baird assumed coverage on Maximus in a research report on Sunday, September 3rd. They issued a “neutral” rating on the stock. Zacks Investment Research cut Maximus from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Maxim Group set a $66.00 target price on Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. BidaskClub cut Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Canaccord Genuity cut Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price on the stock. in a research report on Tuesday, July 4th. One research analyst has rated the stock with a sell rating and nine have given a hold rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $62.43.
TRADEMARK VIOLATION WARNING: This piece was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://sportsperspectives.com/2017/09/11/royce-associates-lp-continues-to-hold-position-in-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.